NUP214 Protein (AA 1-97) (GST tag)
-
- Target Alle NUP214 Produkte
- NUP214 (Nucleoporin 214kDa (NUP214))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-97
- Spezies
- Human
-
Quelle
- Wheat germ
- Aufreinigungstag / Konjugat
- Dieses NUP214 Protein ist gelabelt mit GST tag.
- Applikation
- Western Blotting (WB), Affinity Purification (AP), Antibody Array (AA), ELISA
- Verwendungszweck
- NUP214 (Human) Recombinant Protein (Q01)
- Sequenz
- MGDEMDAMIP EREMKDFQFR ALKKVRIFDS PEELPKERSS LLAVSNKYGL VFAGGASGLQ IFPTKNLLIQ NKPGDDPNKI VDKVQGLLVP MKFPIHH
- Produktmerkmale
- Human NUP214 partial ORF ( NP_005076, 1 a.a. - 97 a.a.) recombinant protein with GST-tag at N-terminal.
- Aufreinigung
- in vitro wheat germ expression system
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Best use within three months from the date of receipt of this protein.
-
- Target
- NUP214 (Nucleoporin 214kDa (NUP214))
- Andere Bezeichnung
- NUP214 (NUP214 Produkte)
- Synonyme
- CAN Protein, CAN/Nup214 Protein, CG3820 Protein, DCAN Protein, DNup214 Protein, Dmel\\CG3820 Protein, Nup 214 Protein, dCAN Protein, l(2)10444 Protein, nup214 Protein, NUP214 Protein, RGD1304977 Protein, BC039282 Protein, D2H9S46E Protein, CAIN Protein, D9S46E Protein, N214 Protein, p250 Protein, Nucleoporin 214kD Protein, nucleoporin 214kDa Protein, nucleoporin 214 Protein, Nup214 Protein, NUP214 Protein
- Hintergrund
-
Full Gene Name: nucleoporin 214 kDa
Synonyms: CAIN,CAN,D9S46E,MGC104525,N214 - Gen-ID
- 8021
- NCBI Accession
- NM_005085
- Pathways
- Protein targeting to Nucleus, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-